Pages that link to "Q69313856"
Jump to navigation
Jump to search
The following pages link to Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis (Q69313856):
Displaying 32 items.
- Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity (Q21284512) (← links)
- Immunoablation and Stem Cell Transplantation in Amyotrophic Lateral Sclerosis: The Ultimate Test for the Autoimmune Pathogenesis Hypothesis (Q26768124) (← links)
- Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease (Q30811549) (← links)
- A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis (Q33590978) (← links)
- Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis. (Q33689422) (← links)
- Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders (Q35068792) (← links)
- Autoimmunity in Amyotrophic Lateral Sclerosis: Past and Present (Q35147143) (← links)
- Effect of thymic stimulation of CD4 T cell expansion on disease onset and progression in mutant SOD1 mice. (Q35176619) (← links)
- Immune aging, dysmetabolism, and inflammation in neurological diseases (Q35677347) (← links)
- Motor neuron-immune interactions: the vicious circle of ALS. (Q36437332) (← links)
- Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival (Q36602163) (← links)
- T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. (Q36968498) (← links)
- CD4-positive T cell-mediated neuroprotection requires dual compartment antigen presentation (Q37149908) (← links)
- Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction (Q37379552) (← links)
- Towards retinoid therapy for Alzheimer's disease (Q37515508) (← links)
- Microglia in ALS: the good, the bad, and the resting (Q37592030) (← links)
- ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity (Q37677431) (← links)
- The multifaceted role of glial cells in amyotrophic lateral sclerosis (Q38126396) (← links)
- Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis (Q38150127) (← links)
- CD4 T Cells and Neuroprotection: Relevance to Motoneuron Injury and Disease. (Q38543215) (← links)
- Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis. (Q39561307) (← links)
- The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches (Q41107984) (← links)
- Proximate Mediators of Microvascular Dysfunction at the Blood-Brain Barrier: Neuroinflammatory Pathways to Neurodegeneration (Q41613567) (← links)
- The TGF-β System As a Potential Pathogenic Player in Disease Modulation of Amyotrophic Lateral Sclerosis (Q49265933) (← links)
- Development of ALS-like disease in SOD-1 mice deficient of B lymphocytes (Q51772657) (← links)
- Innate immune adaptor TRIF deficiency accelerates disease progression of ALS mice with accumulation of aberrantly activated astrocytes. (Q52724841) (← links)
- Amyotrophic lateral sclerosis (Q59219368) (← links)
- GABA receptor encephalitis in a patient diagnosed with amyotrophic lateral sclerosis (Q64092132) (← links)
- Inflammatory cells in the peripheral nervous system in motor neuron disease (Q70717078) (← links)
- Amyotrophic Lateral Sclerosis (Q73238977) (← links)
- From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis (Q83940098) (← links)
- The Peripheral Immune System and Amyotrophic Lateral Sclerosis (Q94561279) (← links)